Intercellular mRNA transfer alters the human pluripotent stem cell state

Y Yosuke Yoneyama (Human Biology Research Unit, Institute of Integrated Research, Institute of Science Tokyo) R Ran-Ran Zhang (Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center) M Mari Maezawa (Human Biology Research Unit, Institute of Integrated Research, Institute of Science Tokyo) H Hideki Masaki (Stem Cell Therapy Division, Institute of Integrated Research, Institute of Science Tokyo) M Masaki Kimura (Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center) Y Yuqi Cai (Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center) M Mike Adam (Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center) S Sreeja Parameswaran (Center for Autoimmune Genomics and Etiology, Cincinnati Children’s Hospital Medical Center) N Naoaki Mizuno (Stem Cell Therapy Division, Institute of Integrated Research, Institute of Science Tokyo) J Joydeep Bhadury (Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine) S So Maezawa (Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science) H Hiroshi Ochiai (Division of Gene Expression Dynamics, Medical Institute of Bioregulation, Kyushu University) H Hiromitsu Nakauchi S S. Steven Potter (Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center) M Matthew T. Weirauch (Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center) T Takanori Takebe

Abstract

Intercellular transmission of messenger RNA (mRNA) is being explored in mammalian species using immortal cell lines. Here, we uncover an intercellular mRNA transfer phenomenon that allows for the adaptation and reprogramming of human primed pluripotent stem cells (hPSCs). This process is induced by the direct cell contact-mediated coculture with mouse embryonic stem cells under the condition impermissible for primed hPSC culture. Mouse-derived mRNA contents are transmitted into adapted hPSCs only in the coculture. Transfer-specific mRNA analysis shows the enrichment for divergent biological pathways involving transcription/translational machinery and stress-coping mechanisms, wherein such transfer is diminished when direct cell contacts are lost. After 5 d of coculture with mouse embryonic stem cells, surface marker analysis and global gene profiling confirmed that mRNA transfer-prone hPSC efficiently gains a naïve-like state. Furthermore, transfer-specific knockdown experiments targeting mouse-specific transcription factor-coding mRNAs in hPSC show that mouse-derived Tfcp2l1 , Tfap2c, and Klf4 are indispensable for human naïve-like conversion. Thus, interspecies mRNA transfer triggers cellular reprogramming in mammalian cells. Our results support that episodic mRNA transfer can occur in cell cooperative and competitive processes, which provides a fresh perspective on understanding the roles of mRNA mobility for intra- and interspecies cellular communications.

Article Details

Volume / Issue Vol. 122, Issue 4
Published January 28, 2025
ISSN 0027-8424
Publisher National Academy of Sciences

Authors (16)

Y

Yosuke Yoneyama

Human Biology Research Unit, Institute of Integrated Research, Institute of Science Tokyo

R

Ran-Ran Zhang

Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center

M

Mari Maezawa

Human Biology Research Unit, Institute of Integrated Research, Institute of Science Tokyo

H

Hideki Masaki

Stem Cell Therapy Division, Institute of Integrated Research, Institute of Science Tokyo

M

Masaki Kimura

Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center

Y

Yuqi Cai

Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center

M

Mike Adam

Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center

S

Sreeja Parameswaran

Center for Autoimmune Genomics and Etiology, Cincinnati Children’s Hospital Medical Center

N

Naoaki Mizuno

Stem Cell Therapy Division, Institute of Integrated Research, Institute of Science Tokyo

J

Joydeep Bhadury

Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine

S

So Maezawa

Department of Applied Biological Science, Faculty of Science and Technology, Tokyo University of Science

H

Hiroshi Ochiai

Division of Gene Expression Dynamics, Medical Institute of Bioregulation, Kyushu University

H

Hiromitsu Nakauchi

S

S. Steven Potter

Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center

M

Matthew T. Weirauch

Division of Gastroenterology, Hepatology & Nutrition, Cincinnati Children’s Hospital Medical Center

T

Takanori Takebe